메뉴 건너뛰기




Volumn 29, Issue 5, 2014, Pages 257-260

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis;Experiencia clínica con los cannabinoides en la terapia de la espasticidad en la esclerosis múltiple

Author keywords

Cannabidiol; Cannabinoids; Delta 9 tetrahydrocannabinol; Effectiveness; Multiple sclerosis; Spasticity

Indexed keywords

CANNABIDIOL; DRONABINOL; ANALGESIC AGENT;

EID: 84901650633     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2013.06.014     Document Type: Article
Times cited : (20)

References (15)
  • 1
    • 4444288689 scopus 로고    scopus 로고
    • Prevalence and treatment of spasticity reported by multiple sclerosis patients
    • Rizzo M.A., Hadjimichael O.C., Preiningerova J., Vollmer T.L. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004, 10:589-595.
    • (2004) Mult Scler , vol.10 , pp. 589-595
    • Rizzo, M.A.1    Hadjimichael, O.C.2    Preiningerova, J.3    Vollmer, T.L.4
  • 2
    • 84878024159 scopus 로고    scopus 로고
    • Spasticity in multiple sclerosis: Results of a patient survey
    • Oreja-Guevara C., González-Segura D., Vila C. Spasticity in multiple sclerosis: Results of a patient survey. Int J Neurosci 2013, 123:400-408.
    • (2013) Int J Neurosci , vol.123 , pp. 400-408
    • Oreja-Guevara, C.1    González-Segura, D.2    Vila, C.3
  • 3
    • 84862895347 scopus 로고    scopus 로고
    • Spasticity and everyday life in multiple sclerosis
    • Donzé C., De Sèze J. Spasticity and everyday life in multiple sclerosis. Rev Neurol (Paris) 2012, 168:S51-S56.
    • (2012) Rev Neurol (Paris) , vol.168
    • Donzé, C.1    De Sèze, J.2
  • 4
    • 0346733218 scopus 로고    scopus 로고
    • Treatments for spasticity and pain in multiple sclerosis: A systematic review
    • Beard S., Hunn A., Wight J. Treatments for spasticity and pain in multiple sclerosis: A systematic review. Health Technol Assess 2003, 7:1-111.
    • (2003) Health Technol Assess , vol.7 , pp. 1-111
    • Beard, S.1    Hunn, A.2    Wight, J.3
  • 6
    • 52949104790 scopus 로고    scopus 로고
    • The endocannabinoid system and multiple sclerosis
    • Baker D., Pryce G. The endocannabinoid system and multiple sclerosis. Curr Pharm Des 2008, 14:2326-2336.
    • (2008) Curr Pharm Des , vol.14 , pp. 2326-2336
    • Baker, D.1    Pryce, G.2
  • 8
    • 84901678851 scopus 로고    scopus 로고
    • Ficha técnica Sativex® (delta-9-tetrahidrocannabinol/cannabidiol) [consultado 1 Feb 2013]. European Medicines Agency. Disponible en:
    • Ficha técnica Sativex® (delta-9-tetrahidrocannabinol/cannabidiol) [consultado 1 Feb 2013]. European Medicines Agency. Disponible en: http://www.aemps.gob.es/cima/especialidad.do%3Fmetodo=verFichaWordPdf%26codigo=72544%26formato=pdf%26formulario=FICHAS%26file=ficha.pdf.
  • 9
    • 84867255279 scopus 로고    scopus 로고
    • Tratamiento de la espasticidad en la esclerosis múltiple: nuevas perspectivas con el uso de cannabinoides
    • Oreja-Guevara C. Tratamiento de la espasticidad en la esclerosis múltiple: nuevas perspectivas con el uso de cannabinoides. Rev Neurol 2012, 55:421-430.
    • (2012) Rev Neurol , vol.55 , pp. 421-430
    • Oreja-Guevara, C.1
  • 10
  • 11
    • 68649086665 scopus 로고    scopus 로고
    • A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis
    • Anwar K., Barnes M.P. A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis. Neurorehabilitation 2009, 24:333-340.
    • (2009) Neurorehabilitation , vol.24 , pp. 333-340
    • Anwar, K.1    Barnes, M.P.2
  • 12
    • 0023130157 scopus 로고
    • Interrater reliability of a modified Ashworth scale of muscle spasticity
    • Bohannon R.W., Smith M.B. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987, 67:206-207.
    • (1987) Phys Ther , vol.67 , pp. 206-207
    • Bohannon, R.W.1    Smith, M.B.2
  • 14
    • 84856757851 scopus 로고    scopus 로고
    • A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
    • Notcutt W., Langford R., Davies P., Ratcliffe S., Potts R. A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols). Mult Scler 2012, 18:219-228.
    • (2012) Mult Scler , vol.18 , pp. 219-228
    • Notcutt, W.1    Langford, R.2    Davies, P.3    Ratcliffe, S.4    Potts, R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.